Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited has disclosed a significant acquisition of shares by its director, Tracey Leigh Batten. Batten increased her holding from 1,772 to 4,500 ordinary shares through a market purchase, reflecting a substantial investment in the company. This transaction, valued at NZD 77,020.61, signifies confidence in the company’s future prospects and may influence stakeholder perceptions positively.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a wide range of products and services across Australasia. The company focuses on the distribution and wholesale of healthcare, medical, and pharmaceutical products, as well as animal care products.
Average Trading Volume: 140,198
Technical Sentiment Signal: Sell
Current Market Cap: A$5.16B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.